Company Valuation: Mesa Laboratories, Inc.

Data adjusted to current consolidation scope
Fiscal Period: March 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,337 934.1 591.9 644.8 488.5 557.7 -
Change - -30.14% -36.64% 8.93% -24.23% 14.17% -
Enterprise Value (EV) 1,506 1,084 591.9 644.8 488.5 557.7 557.7
Change - -27.99% -45.42% 8.93% -24.23% 14.17% 0%
P/E 728x 1,028x -2.32x -330x 73.1x 74.2x 47.1x
PBR 3.41x 2.38x 4.07x 4.05x 2.62x 2.69x 2.49x
PEG - -20x 0x 3.3x -0x 6x 0.8x
Capitalization / Revenue 7.25x 4.26x 2.74x 2.68x 1.96x 2.15x 2.05x
EV / Revenue 0x 0x 0x 0x 0x 2.15x 2.05x
EV / EBITDA 0x 0x 0x 0x 0x 8.83x 8.31x
EV / EBIT 0x 0x 0x 0x 0x 8.49x 7.92x
EV / FCF 0x 0x 0x 0x 0x 13.9x 12.6x
FCF Yield 2.6% 2.51% 7.02% 6.6% 8.1% 7.17% 7.94%
Dividend per Share 2 0.64 0.64 0.64 0.64 0.64 0.64 0.64
Rate of return 0.25% 0.37% 0.58% 0.54% 0.72% 0.63% 0.63%
EPS 2 0.35 0.17 -47.2 -0.36 1.21 1.36 2.143
Distribution rate 183% 376% -1.36% -178% 52.9% 47.1% 29.9%
Net sales 1 184.3 219.1 216.2 241 249.1 259.2 272.2
EBITDA 1 41.16 49.68 50.5 56.74 63.49 63.2 67.1
EBIT 1 37.9 45.82 50.5 51.36 58.23 65.7 70.4
Net income 1 1.871 0.93 -254.2 -1.974 6.712 7.567 12.13
Net Debt 169 150.4 - - - - -
Reference price 2 254.88 174.73 109.73 118.66 88.42 100.95 100.95
Nbr of stocks (in thousands) 5,246 5,346 5,394 5,434 5,525 5,525 -
Announcement Date 5/31/22 5/25/23 6/5/24 5/28/25 5/27/26 - -
1USD in Million2USD
Estimates

P/E, Detailed evolution

P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
74.23x - - 0.63% 558M
28.57x3.95x15.37x2.57% 175B
18.61x3.27x11.49x3.63% 105B
16.97x0.19x11.99x0.78% 59.35B
31.34x7.61x19.89x1.28% 50.71B
38.12x3.05x10.41x2.52% 42.15B
36.08x1.33x11.7x0.27% 31.82B
28.79x5.12x16.34x-.--% 27.2B
41.9x7.46x26.85x0.25% 25.11B
23.19x3.39x12.2x1.25% 20.53B
Average 33.78x 3.93x 15.14x 1.32% 53.79B
Weighted average by Cap. 27.27x 3.72x 14.52x 2.02%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

Year-on-year evolution of the Yield

  1. Stock Market
  2. Stocks
  3. MLAB Stock
  4. Valuation Mesa Laboratories, Inc.